199 related articles for article (PubMed ID: 17540641)
1. Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report.
Saiag P; Bosquet L; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dréno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Négrier S;
Eur J Dermatol; 2007; 17(4):325-31. PubMed ID: 17540641
[No Abstract] [Full Text] [Related]
2. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
3. [Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ; ; ; ; ; ; ;
Bull Cancer; 2006 Apr; 93(4):371-84. PubMed ID: 16714227
[TBL] [Abstract][Full Text] [Related]
4. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
Dummer R; Panizzon R; Bloch PH; Burg G;
Dermatology; 2005; 210(1):39-44. PubMed ID: 15604544
[TBL] [Abstract][Full Text] [Related]
5. Massive nodular melanoma: a case report.
Harting M; Tarrant W; Kovitz CA; Rosen T; Harting MT; Souchon E
Dermatol Online J; 2007 May; 13(2):7. PubMed ID: 17498426
[TBL] [Abstract][Full Text] [Related]
6. Management of Stage I cutaneous melanoma.
Berdeaux DH; Moon TE; Meyskens FL
Ariz Med; 1983 Nov; 40(11):768-72. PubMed ID: 6661064
[No Abstract] [Full Text] [Related]
7. [After excision of primary stage I cutaneous melanoma, is an initial evaluation necessary?].
Richard-Lallemand MA
Ann Dermatol Venereol; 1995; 122(5):349-59. PubMed ID: 8572478
[No Abstract] [Full Text] [Related]
8. Cutaneous melanoma: detecting it earlier, weighing management options.
Lane JE; Dalton RR; Sangueza OP
J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
[No Abstract] [Full Text] [Related]
9. Management of primary cutaneous and metastatic melanoma.
Rubin KM
Semin Oncol Nurs; 2013 Aug; 29(3):195-205. PubMed ID: 23958217
[TBL] [Abstract][Full Text] [Related]
10. [2008 Update of Standards, Options: recommendations for management of patients with salivary gland malignant tumours (excluding lymphoma, sarcoma and melanoma), summary report].
Bensadoun RJ; Dassonville O; Rousmans S
Bull Cancer; 2008; 95(7):735-49. PubMed ID: 18755651
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial of local immunomodulation with DNCB in cases of advanced melanoma of the skin].
Budzanowska E; Pawlicki M
Przegl Dermatol; 1988; 75(1):29-34. PubMed ID: 3290999
[No Abstract] [Full Text] [Related]
12. [Are there special therapeutic methods recommended by some physicians for the management of stage I melanoma?].
Revuz J
Ann Dermatol Venereol; 1995; 122(5):319-20. PubMed ID: 8572474
[No Abstract] [Full Text] [Related]
13. [2003 Update of Standards, Options and Recommendations for management of patients with salivary gland malignant tumors (excluding lymphoma, sarcoma and melanoma) (summary report)].
Bensadoun RJ; Allavena C; Chauvel P; Dassonville O; Demard F; Dieu-Bosquet L; Lacau St Guily J; Ettore F; Gory-Delabaere G; Marcy PY; Reyt E; ; ; ; ; ;
Bull Cancer; 2003 Jul; 90(7):629-42. PubMed ID: 12957805
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic evaluation of malignant melanoma].
Schmoeckel C; Bockelbrink A; Bockelbrink H; Braun-Falco O
Med Klin Prax; 1982 Sep; 77(19):50-1. PubMed ID: 7132900
[No Abstract] [Full Text] [Related]
15. [Melanoma malignancy].
Tilgen W
Hautarzt; 2008 Jun; 59(6):467-8. PubMed ID: 18463839
[No Abstract] [Full Text] [Related]
16. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
[TBL] [Abstract][Full Text] [Related]
17. [Malignant melanoma. Prognostic factors].
Schnyder UW
Schweiz Rundsch Med Prax; 1988 Apr; 77(17):453-5. PubMed ID: 3375670
[No Abstract] [Full Text] [Related]
18. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
Dummer R; Guggenheim M; Arnold AW; Braun R; von Moos R;
Swiss Med Wkly; 2011; 141():w13320. PubMed ID: 22180245
[TBL] [Abstract][Full Text] [Related]
19. Advances in the management of melanoma.
Schneeberger A; Stingl G
Cancer Chemother Biol Response Modif; 2002; 20():519-58. PubMed ID: 12703223
[No Abstract] [Full Text] [Related]
20. [Question of the month. Should treatment of Dubreuilh's melanoma be carcinologic?].
Ann Dermatol Venereol; 1993; 120(6-7):506-8. PubMed ID: 8279802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
